2011年至2014年鲍曼不动杆菌临床感染分布及耐药性分析.docVIP

精品论文 参考文献 2011年至2014年鲍曼不动杆菌临床感染分布及耐药性分析 1新疆昌吉州奇台县人民医院检验科 831800；2新疆昌吉州人民医院输血科 831100；3新疆昌吉州人民医院检验科 831100 【摘 要】目的 对昌吉州人民医院2011年1月至2014年12月临床分离的鲍曼不动杆菌672例回顾性的对其临床科室分布、标本来源及耐药性进行分析，为临床合理使用抗菌药物、严格控制医院感染提供依据。方法 应用法国生物梅里埃公司VITEK-2 Compact全自动微生物系统及鉴定卡、药敏试验卡分析鲍曼不动杆菌的临床科室分布、标本来源及耐药性分析。结果 鲍曼不动杆菌的来源主要来自重症监护室及呼吸科；主要以痰液标本检出鲍曼不动杆菌的检出率最高，可达80.8%，其次为创面分泌物；鲍曼不动杆菌对亚胺培南的耐药率逐年上升，由2011年39.9%上升至2014年60.1%，2014年较前几年耐药率均有所升高。结论 鲍曼不动杆菌感染在重症监护室最为严重，且对常用药物普遍耐药，对碳青霉烯类抗菌药物的耐药率明显上升，应加强对鲍曼不动杆菌的耐药监测，防止耐药菌的蔓延。 【关键词】鲍曼不动杆菌；抗菌药物；耐药性分析 From 2011 to 2014 acinetobacter baumannii clinical infection distribution and drug resistance analysis [Abstract] Objective For once.during peoples hospital of course between January 2011 and December 2011，672 cases of clinical separated acinetobacter baumannii were retrospectively the clinical departments of distribution，specimen source and resistance analysis，for clinical rational use of antimicrobial agents，strictly control the hospital infection provides the basis.Methods Application of biological merry Emmanuel France VITEK - 2 Compact automatic microbial system and identification card，drug sensitive test card analysis of acinetobacter baumannii clinical departments source distribution，specimen and resistance analysis.Result The source of acinetobacter baumannii mainly comes from the intensive care unit and respiratory；followed by wound secretion；Acinetobacter baumannii to resistant rate increased year by year，from the south of 60.1% in 2014，up from 39.9% in 2011，is a few years ago，has higher percentages of 2014.Conclusion Acinetobacter baumannii infection in intensive care unit is most serious，and is generally resistant to commonly used drugs，on carbon penicillium alkene antimicrobial drug resistant rate rise obviously，should strengthen the monitoring of drug resistance of acinetobacter baumannii，to prevent the spread of drug-resistant bacteria. [Key words]Acinetobacter baumannii；Antimicrobial agents；Drug resistance analysis